Clinical impact of circulating LAPTM4B-35 in pancreatic ductal adenocarcinoma

ConclusionLAPTM4B-35 is significantly deregulated in PDAC with high diagnostic and prognostic impact as circulating tumor marker.
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research